Internally Environment-Responsive Nanomaterials

As mentioned earlier, the increasing antibiotic resistance presents significant challenges to the traditional antibiotic treatment of Helicobacter pylori infections. To overcome these challenges, researchers are gradually shifting toward nonantibiotic treatment strategies aimed at effectively inhibiting or eradicating H. pylori through various physical, chemical, or biological methods while minimizing the risk of resistance. These innovative strategies include vaccine development, immunotherapy, probiotic regulation, antimicrobial peptides, and more recently, the emergence of nanomedicine materials, which have shown immense potential in this field [1]. Among the applications of nanomedicine materials, environment-responsive nanocarriers have garnered significant attention [2]. Compared to traditional drug delivery systems, these nanocarriers are capable of responding to specific environmental signals at the stomach or infection sites, such as pH changes, elevated enzyme concentrations, and abnormal redox states, thereby enabling the selective release and precise targeting of drugs [3]. This “smart response” feature allows for the efficient release of drugs at the site of infection, enhancing therapeutic efficacy while minimizing damage to normal tissues.